Sponsor:
Genentech, Inc.
Code:
NCT04302025
Conditions
Non-small Cell Lung Cancer
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Alectinib
Entrectinib
Vemurafenib (Enrollment closed)
Cobimetinib (Enrollment closed)
Pralsetinib (Enrollment closed)
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2025-07-02. This information was provided to ClinicalTrials.gov by Genentech, Inc. on 2025-05-18.